| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583593A1 Ophthalmic compositions for treating ocular hypertension |
| 04/27/2006 | CA2582090A1 Purification of tegaserod maleate |
| 04/26/2006 | EP1650235A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer |
| 04/26/2006 | EP1648885A1 Novel compounds |
| 04/26/2006 | EP1648867A1 Ppar active compounds |
| 04/26/2006 | EP1648861A1 Process for the preparation of cpla 2 inhibitors |
| 04/26/2006 | EP1648856A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 04/26/2006 | EP1648446A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648445A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648444A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648443A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 04/26/2006 | EP1294689B1 Preparation method of a novel beta crystalline form of perindopril tert-butylamine salt |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1764635A carboxylic acid compounds |
| 04/26/2006 | CN1763042A Preparation method of indole-containing heterocycle pyridinedihydrofuranketone |
| 04/26/2006 | CN1763041A N,Núº-dipyridyl-equibenzyl-tetraformyldiimine derivative and its synthesis method |
| 04/26/2006 | CN1763039A Indolizine carboxyl acid analog compound synthesis method |
| 04/26/2006 | CN1763006A Benzcarbazole compound and organic electroluminescent equipment thereof |
| 04/26/2006 | CN1763005A Preparation method and medical uses of Nú¿1ú®-hydrocarbyl-3íõ-nitrotylindirubin derivative 1 |
| 04/26/2006 | CN1763004A Method of separating imide compound |
| 04/26/2006 | CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines |
| 04/25/2006 | US7034164 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 04/25/2006 | US7034163 From alkoxycyclopropane with nitrile in presence of Lewis acid catalyst |
| 04/25/2006 | US7034162 Refluxing aqueous solution of sumatriptan, or salt thereof, in alcoholic solvents |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034052 Anticancer agents; inflammatory bowel disorders; myelodysplastic syndrome |
| 04/25/2006 | US7034050 Animal growth regulators |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034029 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/20/2006 | WO2006041961A1 Arylthioindole tubulin polymerization inhibitors and methods of treating or preventing cancer using same |
| 04/20/2006 | WO2006041156A1 Squarylium compound, photo-electric converting material comprising the same, photo-electric converting element, and photoelectrochemical cell |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006040180A1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040176A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040131A1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | WO2005023255A3 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 04/20/2006 | US20060084815 For therapy and prophylaxis of cancer, inflammatory bowel disease and myelodysplastic syndrome |
| 04/20/2006 | US20060084702 (2S)-2-ethylphenylpropionic acid derivative |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060083943 Phosphorescent compositions and organic light emitting devices containing therm |
| 04/20/2006 | US20060083695 preventing the decomposition of monatin from exposure to ultraviolet light; preserving monatin in a stable state under acidic conditions; use in food, a beverage, a mouth cavity composition, and a pharmaceutical product |
| 04/20/2006 | US20060082291 Luminescent material and organic electroluminescent device using the same |
| 04/20/2006 | CA2583973A1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583333A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2582674A1 Compounds for alzheimer's disease |
| 04/19/2006 | EP1647547A1 New hydrated crystalline forms of perindopril erbumine, process for the preparation thereof and pharmaceutical formulations containing these compounds |
| 04/19/2006 | EP1646661A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/19/2006 | EP1646624A1 Indoles useful in the treatment of inflammation |
| 04/19/2006 | EP1646610A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 04/19/2006 | EP1646609A1 Novel chemiluminescent compounds and their use |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1349833B1 Indole and dihydroindole derivatives |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1761666A Polyhydroxylated pyrrolizidine |
| 04/19/2006 | CN1761651A 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 04/19/2006 | CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/19/2006 | CN1760195A Method for separating and purifying 9-nitro camptothecin |
| 04/19/2006 | CN1760182A Method for preparing 5-hydroxyl tryptophan in high purity |
| 04/19/2006 | CN1760181A Indole onium salt and preparation method |
| 04/19/2006 | CN1252052C Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 04/19/2006 | CN1252042C Oximate light initiator |
| 04/19/2006 | CN1251698C Isatis root extract for treating endotoxin blood disease and application |
| 04/18/2006 | US7030262 3-Amino-2-hydroxyalkanoic acids and their prodrugs |
| 04/18/2006 | US7030256 Metal-ligand complexes has a dianionic ligand chelating to the metal; non-metallocene group 4 complexes as polymerization catalyst for preparing isotactic polypropylene, or copolymers of ethylene/olefin; high molecular weight polypropylene with a high melting point |
| 04/18/2006 | US7030248 Isolation of natural L-β-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural L-β-3-indolylalanine |
| 04/18/2006 | US7030214 Ureins derived from α, ω, diamino acids and process for their preparation |
| 04/18/2006 | US7030196 Process for reducing the molecular weight of polypropylene |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/18/2006 | CA2037098C Hexahydrobenz ¢cd! indoles and processes for preparation thereof |
| 04/13/2006 | WO2006038741A1 Method for producing thioether compound |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006038611A1 Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038594A1 N-type calcium channel inhibitor |
| 04/13/2006 | WO2006038464A1 Cyanine compounds and optical recording materials |
| 04/13/2006 | WO2006037996A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 04/13/2006 | WO2006037982A2 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 04/13/2006 | WO2006008250A3 Oxime derivatives and the use therof as latent acids |
| 04/13/2006 | WO2005116027A3 Indazole and indolone derivatives and their use as pharmaceuticals |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079708 7-(Substituted (hetero)aryl)-3,5-dihydroxy-6-heptenoates, e.g., methyl [R*,S*-(E)]-(+-)-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoate; liquid chromatography using as a packing a polysaccharide (cellulose) modified by an alkylphenyl isocyanate or an alkylbenzoic acid |
| 04/13/2006 | US20060079698 Process for the preparation of intermediates of trandolapril and use thereof for the preparation of trandolapril |
| 04/13/2006 | US20060079692 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | CA2583312A1 Process for the preparation of amorphous fluvastatin sodium |